Purchase Order FA864924P0833

Award Date 5/17/24
Potential Completion Date 8/19/24
Potential Value $110K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Herndon, VA 20170, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
494
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
STTR Phase I
Primary Consortia Member
Not listed
Similar Awards
The U.S. Air Force Research Laboratory (AFRL) awarded a $74,948.00 Firm Fixed Price Purchase Order to Perfusion Medical LLC, a small business, for the research and development of PEG-20K/8K, a patented intravenous solution to treat hemorrhagic shock. This Small Business Technology Transfer (STTR) Phase I contract supports Perfusion Medical's efforts to commercialize its novel pipeline product, PEG-20K IV solution, which was originally developed by researchers at Virginia Commonwealth University....
The U.S. Air Force Research Laboratory awarded a $74,975 firm fixed price Small Business Innovation Research (SBIR) Phase I purchase order to Perfusion Medical LLC, a biotechnology company, for the research and development of PEG-20K/8K, a patented intravenous solution for the treatment of acute kidney injury, septic shock, and hemorrhagic shock. The contract is set aside for small businesses. Perfusion Medical LLC is commercializing this solution, which was developed by researchers at...
This is a $1,799,970.00 Firm Fixed Price Purchase Order awarded by the Air Force Research Laboratory (AFRL) to Perfusion Medical LLC, a small biotechnology company, to conduct a human clinical trial for the safety of PM-208, an anti-shock drug. The contract is a Small Business Technology Transfer (STTR) Phase II award, which supports the company's research and development of a novel intravenous solution called PEG-20K for treating acute medical conditions like septic shock, hemorrhagic shock,...
The Department of the Air Force Materiel Command Research Laboratory awarded a $1,799,322.00 firm fixed price purchase order to Perfusion Medical LLC, a biotechnology company, for the research and development of optimal dosing and formulation of PM-208 (PEG-20K/8K) for use in the Air Force field. This Phase II Small Business Technology Transfer (STTR) contract is a follow-on to previous STTR Phase I awards the company received from the Air Force to study the use of PEG-20K/8K intravenous...
The U.S. Air Force Research Laboratory (AFRL) awarded a $1,249,578.00 Firm Fixed Price contract to 410 Medical, Inc., a small business manufacturer of medical devices, to develop an Ultra Lightweight Rapid Infuser and conduct testing for integration with fluid warmers. This is a Phase II Small Business Innovation Research (SBIR) program contract with a period of performance through May 29, 2026. 410 Medical specializes in rapid infusion and blood delivery devices for combat casualty care and...
<p>This is a $74,836 firm fixed-price purchase order awarded by the Air Force Research Laboratory (AFRL) to Monumedical, LLC, a small business, under the SBIR (Small Business Innovation Research) Program Phase I. The contract is for the development of the MINIFUSER infusion device for prolonged field care. The period of performance for this award is from January 17, 2025, to April 17, 2025.</p>
This is a $1,798,713 firm fixed-price purchase order awarded by the Air Force Research Laboratory (AFRL) to 410 Medical, Inc., a small business manufacturer, for the development of the LifeFlow Helios, a novel high-efficiency portable fluid warmer. The contract is a Small Business Innovation Research (STTR) Phase II award, building on prior Phase I work, to advance technology enabling urgent trauma care and rapid resuscitation for the military. 410 Medical, a medical device company, has received...
The U.S. Air Force Research Laboratory (AFRL) awarded a $1,245,650.00 SBIR Phase II contract to Nanoguard Medical Solutions, LLC, a small disadvantaged business, for the development of a &quot;SAVING LIVES IN COMBAT - A REVOLUTIONARY NANOFIBER WOUND CARE&quot; product. The contract is a firm fixed-price purchase order with a period of performance through February 17, 2026. This SBIR Phase II action is part of the AFRL's efforts to support the development of innovative technologies for defense...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the Department of the Air Force Materiel Command Research Laboratory to 410 Medical, Inc., a small business manufacturer of medical devices. The contract is for the development of a &quot;Rapid Infusion Device Optimized for Warfighter Resuscitation&quot; with a potential value of $50,000.00. 410 Medical specializes in hand-operated infusion devices for urgent fluid delivery, such as the LifeFlow system, which it...
<p>This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), a civilian agency, to Prolong Pharmaceuticals, Inc. for the &quot;Production of Pegylated Hemoglobin&quot;. The definitive, firm-fixed price contract has a ceiling value of $101,339.00 and a period of performance ending on January 31, 2009. The contract is focused on biomedical, applied/exploratory research and development.</p>

The U.S. Air Force Research Laboratory (AFRL) awarded a $109,917 Firm Fixed Price purchase order contract to Perfusion Medical LLC, a small biotechnology company, for the development of a patented intravenous solution called PEG-20K/8K. This Small Business Technology Transfer (STTR) Phase I contract is focused on researching and developing the PEG-20K/8K solution, which aims to treat critical medical emergencies such as septic shock, hemorrhagic shock, and acute kidney injury. The contract involves objectives like human clinical trials for safety assessments, optimal dosing strategies, and exploring potential applications in treating various shock conditions and acute medical emergencies. Perfusion Medical LLC has previously received federal grant funding, including a $275,000 R41 grant from the National Institute of General Medical Sciences, to support research into using the PEG-20K IV solution to address sepsis by preserving tissue perfusion and protecting endothelial cell glycocalyx.

Generated 2/27/25, 10:00 AM